Advertisement
LETTER TO THE EDITOR| Volume 38, ISSUE 3, P228-230, June 2005

Download started.

Ok

p53-Specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals

      Alteration of the p53 tumor suppressor gene is the most frequent genetic event found in human cancers [
      • Soussi T.
      p53 Antibodies in the sera of patients with various types of cancer: a review.
      ]. A recent review reported a correlation between the presence of a p53-specific antibody response and p53 mutations in the tumors [
      • Soussi T.
      p53 Antibodies in the sera of patients with various types of cancer: a review.
      ]. Titers of p53-specific antibodies have shown to be prognostic markers of lowered survival in patients with breast and colorectal cancers and may serve to detect lung cancer in early stages [
      • Soussi T.
      p53 Antibodies in the sera of patients with various types of cancer: a review.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Soussi T.
        p53 Antibodies in the sera of patients with various types of cancer: a review.
        Cancer Res. 2000; 60: 1777-1788
        • Ziegler A.
        • Jonason A.S.
        • Leffell D.J.
        • Simon J.A.
        • Sharma H.W.
        • Kimmelman J.
        • et al.
        Sunburn and p53 in the onset of skin cancer [see comments].
        Nature. 1994; 372: 773-776
        • McGregor J.M.
        • Berkhout R.J.
        • Rozycka M.
        • Ter Schegget J.
        • Bouwes Bavinck J.N.
        • Brooks L.
        • et al.
        p53 Mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status.
        Oncogene. 1997; 15: 1737-1740
        • Black A.P.
        • Ogg G.S.
        The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.
        Clin Exp Immunol. 2003; 132: 379-384
        • Moch C.
        • Moysan A.
        • Lubin R.
        • De La Salmoniere P.
        • Soufir N.
        • Galisson F.
        • et al.
        Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
        Br J Cancer. 2001; 85: 1883-1886
        • Euvrard S.
        • Kanitakis J.
        • Claudy A.
        Skin cancers after organ transplantation.
        N Engl J Med. 2003; 348: 1681-1691
        • Bavinck J.N.
        • Gissmann L.
        • Claas F.H.
        • Van der Woude F.J.
        • Persijn G.G.
        • Ter Schegget J.
        • et al.
        Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
        J Immunol. 1993; 151: 1579-1586
        • Feltkamp M.C.
        • Broer R.
        • Di Summa F.M.
        • Struijk L.
        • Van der Meijden E.
        • Verlaan B.P.
        • et al.
        Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
        Cancer Res. 2003; 63: 2695-2700
        • Shimada H.
        • Nakajima K.
        • Sakamoto K.
        • Takeda A.
        • Hori S.
        • Hayashi H.
        • et al.
        Existence of serum p53 antibodies in cyclosporine A-treated transplant patients: possible detection of p53 protein over-expression.
        Transplant Proc. 2000; 32: 1779
        • Pyrzynska B.
        • Serrano M.
        • Martinez A.
        • Kaminska B.
        Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A.
        J Biol Chem. 2002; 277: 14102-14108